Does sertraline (Zoloft) interact with the combined oral contraceptive Nextstellis (estradiol and segesterone acetate) in a 19‑year‑old female who has nausea and weight loss after starting the OCP?

No Clinically Significant Drug Interaction Between Zoloft and Nextstellis

Sertraline (Zoloft) does not have a documented pharmacokinetic interaction with Nextstellis (drospirenone/estetrol), and the nausea and weight loss are most likely adverse effects of the oral contraceptive itself rather than a drug interaction.

Drug Interaction Assessment

The FDA label for Nextstellis does not list SSRIs like sertraline as interacting medications 1. The primary drug interactions of concern with Nextstellis involve:

• CYP3A inducers (rifampin, anticonvulsants) that reduce contraceptive efficacy
• Potassium-sparing medications that may cause hyperkalemia with drospirenone
• Hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir 1

Sertraline falls into none of these categories. Historical literature on oral contraceptive interactions focuses on enzyme-inducing anticonvulsants, rifampin, and certain antibiotics—not SSRIs 2, 3, 4. While older studies note that oral contraceptives can inhibit metabolism of certain drugs (benzodiazepines, tricyclic antidepressants), sertraline is not among the commonly affected medications.

The Real Culprit: Nextstellis Side Effects

The nausea and weight loss are consistent with known adverse effects of Nextstellis itself, not a drug interaction. The FDA label explicitly lists the most common adverse reactions (≥2%) as:

• Bleeding irregularities
• Mood disturbance
• Headache
• Breast symptoms
• Dysmenorrhea
• Acne
• Weight increased 1

Critical Caveat on Weight Changes

Note that the FDA label lists "weight increased" as a common side effect, yet this patient reports weight loss. This warrants attention:

• Nausea from oral contraceptives can lead to decreased oral intake and subsequent weight loss
• The combination of nausea and weight loss may indicate poor tolerance to this specific formulation
• Consider whether the weight loss is intentional (due to nausea-induced anorexia) or unintentional

Clinical Management Algorithm

1. Reassure regarding drug interaction: No evidence suggests sertraline reduces Nextstellis efficacy or causes the reported symptoms

2. Address the nausea:

   • If mild and improving: Continue current regimen, take with food
   • If moderate-to-severe or persistent beyond 2-3 cycles: Consider switching to a different OCP formulation with lower estrogen content or different progestin

3. Monitor weight loss:

   • If >5% body weight loss or ongoing: Strongly consider discontinuing Nextstellis
   • Document baseline BMI—Nextstellis may be less effective in females with BMI ≥30 kg/m² 1

4. Alternative contraceptive options if symptoms persist:

   • Lower-dose combined oral contraceptives
   • Progestin-only methods (if estrogen is the culprit)
   • Non-hormonal methods (copper IUD)

Important Pitfall to Avoid

Do not assume all side effects during multi-drug therapy are due to interactions. Most adverse effects in patients on oral contraceptives are from the contraceptive itself, not drug-drug interactions. The evidence shows that serious OCP interactions are actually uncommon 3, and sertraline is not among the documented interacting drugs.

The patient should continue both medications if the nausea is tolerable, but if symptoms persist beyond 2-3 cycles or worsen, switching to a different contraceptive formulation is warranted—not because of an interaction with sertraline, but because of poor tolerance to Nextstellis.